Handbook of sleep disorders in medical conditions / edited by Josée Savard, Marie-Christine Ouellet.
Material type: TextPublisher: London, United Kingdom : Academic Press, an imprint of Elsevier, 2019Description: 1 online resourceContent type:- text
- computer
- online resource
- 9780128130155
- 0128130156
- 616.8/498 23
- RC547
Item type | Current library | Shelving location | Call number | Status | Date due | Barcode | Item holds | |
---|---|---|---|---|---|---|---|---|
Electronic Book | Kuakarun Nursing Library | Processing unit | Online Access | Eb34973 |
Includes index.
Online resource; title from PDF title page (ScienceDirect, viewed March 19, 2019).
Front Cover; Handbook of Sleep Disorders in Medical Conditions; Copyright Page; Contents; List of Contributors; Preface; References; I. General Issues; 1 Diagnostic Criteria and Assessment of Sleep Disorders; Introduction; Current Diagnostic Classification Systems; Clinical Features and Diagnostic Considerations for Sleep/Wake Disorders; Insomnia; Hypersomnolence; Narcolepsy; Breathing-Related Sleep Disorders; Circadian Rhythm Sleep-Wake Disorders; Parasomnias; Movement-Related Sleep Disorders; Psychological, Behavioral, and Laboratory Assessments to Aid Diagnosis; Clinical History
Daily Self-MonitoringSelf-Report Questionnaires; Actigraphy; Polysomnography; Multiple Sleep Latency Test; Maintenance of Wakefulness Test; Areas for Future Research; Conclusion; References; 2 Treatment of Insomnia; Introduction; Epidemiology of Insomnia; Diagnostic Considerations; Conceptual Model of Insomnia; Current Treatment Options; Cognitive-Behavioral Therapies; Sleep Restriction; Stimulus Control Therapy; Relaxation-Based Interventions and Mindfulness; Cognitive Therapy; Sleep Hygiene Education; Multifaceted Cognitive-Behavioral Therapy; Indications and Rationale; Pharmacotherapy
Benzodiazepine Receptor AgonistsChronobiotic Agents: Melatonin Agonists and Related Compounds; Orexin Receptor Antagonist; Off-Label Use of Pharmacotherapy for Insomnia; Antidepressants; Antipsychotics; Anticonvulsants; Over-the-Counter Sleep Aids; Natural Products; Bright Light Therapy; Acupuncture; Summary of Outcome Evidence; Impact of Treatment on Nighttime and Daytime Symptoms; Combined Cognitive-Behavioral Therapy and Medication; Short-Term and Long-Term Outcomes; Treatment Delivery Models; Clinical and Practical Considerations; Areas for Future Research; Summary and Conclusion
Indications to TreatTypes of Devices; Continuous (Constant) Positive Airway Pressure; Autotitrating Continuous Positive Airway Pressure; Bilevel Positive Airway Pressure in Spontaneous Mode; Oral Appliance Therapy; Behavioral Modification; Other Therapies; Approach to Patient Care; Treatment of Central Sleep Apnea Syndromes; Central Sleep Apnea With Cheyne-Stokes Breathing; Indications to Treat; Type of Devices; Approach to Patient Care; Central Sleep Apnea Due to Opioid Use; Indications to Treat; Type of Devices; Approach to Patient Care; Primary or Idiopathic Central Sleep Apnea
Master record variable field(s) change: 072
There are no comments on this title.